These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11554433)

  • 21. In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.
    Barra JG; Levenson J; Armentano RL; Cabrera Fischer EI; Pichel RH; Simon A
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H859-68. PubMed ID: 9124449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation.
    Minshall RD; Erdös EG; Vogel SM
    Am J Cardiol; 1997 Aug; 80(3A):132A-136A. PubMed ID: 9293966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protective effect of an angiotensin-converting-enzyme inhibitor on neurogenic pulmonary edema in rabbits].
    Chen Y; Song F; Lu G; Lu Z
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):602-6. PubMed ID: 25224238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of zofenopril and ramipril on cough reflex responses in anesthetized and awake rabbits.
    Mutolo D; Bongianni F; Evangelista S; Cinelli E; Pantaleo T
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):384-92. PubMed ID: 20924096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action.
    Norman JT; Stidwill R; Singer M; Fine LG
    Nephron Physiol; 2003; 94(2):p39-46. PubMed ID: 12845221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the mode of cough augmentation by four angiotensin-converting enzyme inhibitors in guinea-pigs.
    Takahama K; Fuchikami J; Suzuki A; Tabata T; Kai H; Miyata T
    J Pharm Pharmacol; 1993 Nov; 45(11):1003-5. PubMed ID: 7908029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Heller J; Kramer HJ; Horácek V
    Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enalaprilat versus cilazaprilat: a comparison of allergic skin reactions in the guinea pig.
    Persson KM; Andersson RG
    Agents Actions; 1991 May; 33(1-2):97-9. PubMed ID: 1716846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough.
    Fox AJ; Lalloo UG; Belvisi MG; Bernareggi M; Chung KF; Barnes PJ
    Nat Med; 1996 Jul; 2(7):814-7. PubMed ID: 8673930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B; Brunner HR
    Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery.
    Onaka U; Fujii K; Abe I; Fujishima M
    Br J Pharmacol; 1997 Nov; 122(5):942-8. PubMed ID: 9384513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs.
    Andersson RG; Karlberg BE; Lindgren BR; Persson K; Rosenqvist U
    Drugs; 1991; 41 Suppl 1():48-53. PubMed ID: 1712272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition.
    Valentin JP; Nafrialdi N; Ribstein J; Mimran A
    Am J Physiol; 1993 Apr; 264(4 Pt 2):R676-80. PubMed ID: 8386485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.
    Barbe F; Su JB; Guyene TT; Crozatier B; Ménard J; Hittinger L
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H1985-92. PubMed ID: 8764248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat.
    Weaver-Osterholtz D; Reams G; De Vergel CF; Bauer JH
    J Urol; 2001 May; 165(5):1735-8. PubMed ID: 11342966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
    Rodrigues MS; Schaffel R; Assreuy J
    Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
    Pylypchuk GB
    Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.